Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J A Wyllie

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|January 25, 2007
Taking the time to study competitive antagonismD J A Wyllie, P E Chen
British Journal of Pharmacology|June 6, 2007
Late-phase, protein synthesis-dependent long-term potentiation in hippocampal CA1 pyramidal neurones with destabilized microtubule networksC A Vickers, D J A Wyllie
Neuroscience|April 2, 2008
In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal deathM-A Martel, D J A Wyllie, G E Hardingham
Neuropharmacology|February 5, 2013
Influence of GluN2 subunit identity on NMDA receptor functionD J A Wyllie, M R Livesey, G E Hardingham
British Journal of Pharmacology|January 22, 2009
Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytesC A Puddifoot, P E Chen, R Schoepfer, et al.
Neuropharmacology|October 20, 2010
Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARsH J Otton, A Lawson McLean, M A Pannozzo, et al.
British Journal of Pharmacology|October 26, 2011
Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonistS McKay, N H Griffiths, P A Butters, et al.
Neuropharmacology|May 15, 2012
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive mannerS Edman, S McKay, L J Macdonald, et al.
Nature Communications|June 14, 2012
SynGAP isoforms exert opposing effects on synaptic strengthA C McMahon, M W Barnett, T S O'Leary, et al.
Nature Communications|March 3, 2011
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground stateR Patani, A J Hollins, T M Wishart, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|January 25, 2007
Taking the time to study competitive antagonismD J A Wyllie, P E Chen
British Journal of Pharmacology|June 6, 2007
Late-phase, protein synthesis-dependent long-term potentiation in hippocampal CA1 pyramidal neurones with destabilized microtubule networksC A Vickers, D J A Wyllie
Neuroscience|April 2, 2008
In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal deathM-A Martel, D J A Wyllie, G E Hardingham
Neuropharmacology|February 5, 2013
Influence of GluN2 subunit identity on NMDA receptor functionD J A Wyllie, M R Livesey, G E Hardingham
British Journal of Pharmacology|January 22, 2009
Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytesC A Puddifoot, P E Chen, R Schoepfer, et al.
Neuropharmacology|October 20, 2010
Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARsH J Otton, A Lawson McLean, M A Pannozzo, et al.
British Journal of Pharmacology|October 26, 2011
Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonistS McKay, N H Griffiths, P A Butters, et al.
Neuropharmacology|May 15, 2012
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive mannerS Edman, S McKay, L J Macdonald, et al.
Nature Communications|June 14, 2012
SynGAP isoforms exert opposing effects on synaptic strengthA C McMahon, M W Barnett, T S O'Leary, et al.
Nature Communications|March 3, 2011
Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground stateR Patani, A J Hollins, T M Wishart, et al.
Pageof 1